I came to Genentech in 2002 after finishing my post-doctoral work in virology at UCSF. Since Joining Genentech I have been working on developing antibody-drug conjugates for the treatment of cancer. Learning the complex, team-oriented process of drug development has been fun and interesting. It has been very exciting to start projects that have the potential to help people and then see that potential start to become a reality.
(2009) Blood 114(13): 2721-9.
My lab works on the development of antibody-drug conjugates (ADCs), cytotoxic drugs chemically linked to antibodies, for the treatment of cancer. Our goal is to provide a means to deliver chemotherapy by targeting the drug to neoplastic cells.